These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 36192502)

  • 21. Aberrant lipid metabolism as a therapeutic target in liver cancer.
    Pope ED; Kimbrough EO; Vemireddy LP; Surapaneni PK; Copland JA; Mody K
    Expert Opin Ther Targets; 2019 Jun; 23(6):473-483. PubMed ID: 31076001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
    Wang R; Zhao J; Jin J; Tian Y; Lan L; Wang X; Zhu L; Wang J
    Lipids Health Dis; 2022 Nov; 21(1):121. PubMed ID: 36384580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol extracts of chickpeas alter the total lipid content and expression levels of genes related to fatty acid metabolism in mouse 3T3-L1 adipocytes.
    Shinohara S; Gu Y; Yang Y; Furuta Y; Tanaka M; Yue X; Wang W; Kitano M; Kimura H
    Int J Mol Med; 2016 Aug; 38(2):574-84. PubMed ID: 27353085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
    Tan SK; Mahmud I; Fontanesi F; Puchowicz M; Neumann CKA; Griswold AJ; Patel R; Dispagna M; Ahmed HH; Gonzalgo ML; Brown JM; Garrett TJ; Welford SM
    Cancer Discov; 2021 Aug; 11(8):2072-2093. PubMed ID: 33757970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
    Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
    Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation.
    Ackerman D; Tumanov S; Qiu B; Michalopoulou E; Spata M; Azzam A; Xie H; Simon MC; Kamphorst JJ
    Cell Rep; 2018 Sep; 24(10):2596-2605.e5. PubMed ID: 30184495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-2α-induced upregulation of CD36 promotes the development of ccRCC.
    Liao M; Li Y; Xiao A; Lu Q; Zeng H; Qin H; Zheng E; Luo X; Chen L; Ruan XZ; Yang P; Chen Y
    Exp Cell Res; 2022 Dec; 421(2):113389. PubMed ID: 36252650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
    Tanaka K; Kandori S; Sakka S; Nitta S; Tanuma K; Shiga M; Nagumo Y; Negoro H; Kojima T; Mathis BJ; Shimazui T; Watanabe M; Sato TA; Miyamoto T; Matsuzaka T; Shimano H; Nishiyama H
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34841437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key Molecules of Fatty Acid Metabolism in Gastric Cancer.
    Li C; Zhang L; Qiu Z; Deng W; Wang W
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
    Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
    Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
    Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z
    Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma.
    Lucarelli G; Ferro M; Loizzo D; Bianchi C; Terracciano D; Cantiello F; Bell LN; Battaglia S; Porta C; Gernone A; Perego RA; Maiorano E; Cobelli O; Castellano G; Vincenti L; Ditonno P; Battaglia M
    Metabolites; 2020 Dec; 10(12):. PubMed ID: 33322148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
    Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
    Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
    Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsa_circ_0086414/transducer of ERBB2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.
    Meng X; Li W; Yu T; Lu F; Wang C; Yuan H; Yang W; Dong W; Xiao W; Zhang X
    Int J Biol Macromol; 2024 Mar; 261(Pt 1):129636. PubMed ID: 38272402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.
    Shi J; Miao D; Lv Q; Wang K; Wang Q; Liang H; Yang H; Xiong Z; Zhang X
    Cell Death Dis; 2023 Aug; 14(8):560. PubMed ID: 37626050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous lipids promote the growth of breast cancer cells via CD36.
    Zhao J; Zhi Z; Wang C; Xing H; Song G; Yu X; Zhu Y; Wang X; Zhang X; Di Y
    Oncol Rep; 2017 Oct; 38(4):2105-2115. PubMed ID: 28765876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.
    Miao D; Wang Q; Shi J; Lv Q; Tan D; Zhao C; Xiong Z; Zhang X
    Cancer Commun (Lond); 2023 Apr; 43(4):480-502. PubMed ID: 36860124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.